Literature DB >> 17156394

Haematopoietic progenitor cells utilise conventional PKC to suppress PKB/Akt activity in response to c-Kit stimulation.

Charlotte E Edling1, Malin Pedersen, Leif Carlsson, Lars Rönnstrand, Ruth H Palmer, Bengt Hallberg.   

Abstract

Receptor tyrosine kinase (RTK) c-Kit signalling is crucial for the proliferation, survival and differentiation of haematopoietic stem cells (HSCs). To further understand the mechanisms underlying these events we explored how the downstream mediators interact. The present study investigated the function of conventional protein kinase Cs (c-PKC) in c-Kit mediated signalling pathways in HSC-like cell lines. This analysis supported earlier findings, that steel factor (SF) activates c-PKC, extracellular signal-regulated kinase (Erk) and protein kinase B (PKB). The present results were consistent with an important role of c-PKC in the positive activation of Erk and for proliferation. Further, it was observed that c-PKC negatively regulated PKB activity upon SF stimulation, indicating that c-PKC acts as a suppressor of c-Kit signalling. Finally, these observations were extended to show that c-PKC mediated the phosphorylation of the endogenous c-Kit receptor on serine 746, resulting in decreased overall tyrosine phosphorylation of c-Kit upon SF stimulation. This report showed that this specific feedback mechanism of c-PKC mediated phosphorylation of the c-Kit receptor has consequences for both proliferation and survival of HSC-like cell lines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17156394     DOI: 10.1111/j.1365-2141.2006.06434.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

Review 1.  A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase.

Authors:  Zhi-Chao Feng; Matthew Riopel; Alex Popell; Rennian Wang
Journal:  Diabetologia       Date:  2015-02-03       Impact factor: 10.122

2.  A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency.

Authors:  Chantal Lagresle-Peyrou; Aurélien Olichon; Hanem Sadek; Philippe Roche; Claudine Tardy; Cindy Da Silva; Alexandrine Garrigue; Alain Fischer; Despina Moshous; Yves Collette; Capucine Picard; Jean Laurent Casanova; Isabelle André; Marina Cavazzana
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

3.  c-Kit Induces Migration of Triple-Negative Breast Cancer Cells and Is a Promising Target for Tyrosine Kinase Inhibitor Treatment.

Authors:  José A López-Mejía; Luis F Tallabs-Utrilla; Pablo Salazar-Sojo; Jessica C Mantilla-Ollarves; Manuel A Sánchez-Carballido; Leticia Rocha-Zavaleta
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.